INCATE and Peak Spirit join forces to support AMR startups on their investment journey
Over the past four years, INCATE has been supporting early-stage [...]
Unison Medicines secures new funding
Unison Medicines is delighted to announce an oversubscribed first close [...]
Double good news at INCATE!
We are happy to announce a new partnership with Granzer [...]
What does AMR sound like?
From bone flutes to synths, music has always been more [...]
Introducing 4 new additions to our portfolio
The INCATE Selection Committee has chosen four new ventures for [...]
Phage Therapy: from Stalingrad to the frontlines against AMR!
Did you know phages helped stop a cholera outbreak in [...]
When Cancer is no longer the biggest threat: AMR’s growing shadow over oncology
In 2025, it is possible — and increasingly common — [...]
The INCATE Management Team is growing!
At INCATE, we are committed to providing support to early-stage [...]
From lab to listing: CEO Marc Gitzinger on BioVersys’ IPO Journey
On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its [...]
Dancing against superbugs: a night of art, science, and urgent conversations in Basel
On the evening of April 9, 2025, The Voltahalle in [...]
